Abbott to release elecare® amino acid-based formulas to help meet critical patient need

Abbott to release limited quantities of elecare® branded specialty formulas product will be released immediately free of charge to children in need parents and caregivers in urgent need should contact their healthcare professionals or abbott at +1-800-881-0876 for additional information abbott plans to restart production at the sturgis facility on june 4 and will prioritize elecare production, with initial elecare product release to consumers beginning on or about june 20 abbott park, ill., may 24, 2022 /prnewswire/ -- abbott (nyse: abt) today announced that the u.s. district court for the western district of michigan has amended the recent consent decree allowing abbott to release limited quantities of its elecare® specialty amino acid-based formulas that were previously on hold following the feb. 17 recall of some powder infant formulas from its sturgis, mich.
ABT Ratings Summary
ABT Quant Ranking